Sodium Bicarbonate → HCID 89782936, compound
Reaction equation
CC1(C)C(C)(C)OB([C:9]2[CH:17]=[C:16]([C:18]([F:21])([F:20])[F:19])[CH:15]=[C:14]3[C:10]=2[CH:11]=[N:12][NH:13]3)O1.Br[C:24]1[CH:25]=[CH:26][C:27]([S:30]([NH:33][CH2:34][CH2:35][OH:36])(=[O:32])=[O:31])=[N:28][CH:29]=1.[C:37](=[O:40])(O)[O-:38].[Na+]>C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].O1CCOCC1>[C:37]([OH:38])([C:18]([F:21])([F:20])[F:19])=[O:40].[OH:36][CH2:35][CH2:34][NH:33][S:30]([C:27]1[CH:26]=[CH:25][C:24]([C:9]2[CH:17]=[C:16]([C:18]([F:19])([F:20])[F:21])[CH:15]=[C:14]3[C:10]=2[CH:11]=[N:12][NH:13]3)=[CH:29][N:28]=1)(=[O:32])=[O:31]Participants
Reactant 3
Product 2
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 140 °C
Procedure
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1H-indazole (40 mg, 0.128 mmol), 5-bromo-N-(2-hydroxyethyl)pyridine-2-sulfonamide (43.2 mg, 0.154 mmol), PdCl2(dppf) (9.38 mg, 0.013 mmol), sodium bicarbonate (0.274 mL, 0.513 mmol), and dioxane (2 mL) were mixed in a 10 mL vial to give an orange suspension. The vial was sealed and then heated to 140° C. for 20 minutes in a microwave reactor. The reaction mixture was subsequently filtered and the product was purified by preparative HPLC, eluting with a gradient of 25-50% ACN (containing 0.035% TFA) in H2O (containing 0.05% TFA). The pure fractions were lyophilized to give a TFA salt of the title compound as a white solid (16.4 mg, 25.6%). 1H NMR (400 MHz, DMSO-d6) δ ppm 3.05 (q, J=6.48 Hz, 2H), 3.40-3.46 (m, 7H), 7.70 (d, J=1.01 Hz, 1H), 7.96 (t, J=5.81 Hz, 1H), 8.08 (dd, J=8.21, 0.88 Hz, 2H), 8.45 (s, 1H), 8.51 (dd, J=8.21, 2.40 Hz, 1H), 9.15 (dd, J=2.27, 1.01 Hz, 1H); ESI-MS m/z [M+H]+ calc'd for C15H13F3N4O3S, 387.1. found 387.2.
Workup
- customto give an orange suspension
- customThe vial was sealed
- filtrationThe reaction mixture was subsequently filtered
- customthe product was purified by preparative HPLC
- washeluting with a gradient of 25-50% ACN (containing 0.035% TFA) in H2O (containing 0.05% TFA)
Sources & evidence
- ORD record
- ord-0ddaf83dd57d4548ad7eaed76e6c9aae
- Source dataset
- uspto-grants-2016_09
- Patent number
- US09434743B2
Reaction notes
Loading…